Industry News

Ross University’s School of Veterinary Medicine opened the $10.5 million Research and Pathology Building in July of 2018 in Basseterre, Saint Kitts. Providing eight laboratories, the 19,000-sf facility offers 13,000 sf of research space, 4,000 sf of student space including a 1,500-sf learning center, and 2,000 sf of pathology space with suites for necropsy and histology. Designed to promote multidisciplinary collaboration and interaction, the building will support the One Health initiative in addressing the interconnectivity of animal, human, and environmental health.

The University of Aberystwyth is planning to create VetHub 1, a human and animal health research facility in the United Kingdom. Located on the Penglais campus in Aberystwyth, the project includes the renovation and expansion of an existing 5,231-sf structure to provide three BSL-3 labs, two BSL-2 labs, and associated office spaces. The facility will support the development of new products, diagnostic tests, and strategies for the nation's agricultural, veterinary, and biotechnology industries. 

Washington State University broke ground in June of 2018 on the $66 million Plant Sciences Building in Pullman. Providing 15 wet labs, three dry labs, and multiple collaboration spaces, the four-story 82,476-sf facility will accommodate research programs in horticulture, plant biochemistry and pathology, and crop and soil science. The project team includes LMN Architects, laboratory design consultant Research Facilities Design (RFD), and design-build contractor Skanska.

Memorial University of Newfoundland is building the CAD$36 million Animal Resource Centre in St. Johns. Replacing two existing buildings, the collaborative 26,000-sf research facility will include rodent production and housing areas, surgical suites for small and large animals, physiological testing areas, and an Animal Containment Level 2 environment for behavioral studies. The project was designed by NXL Architects and will accommodate mice, rats, woodchucks, and Yucatan minipigs.

Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), completed an expansion of its pilot plant in High Point in May of 2018. The project included the installation and commissioning of a fourth reactor suite, increasing the site's capacity by approximately 30 percent. The 400-sf suite houses two 2,000-liter glass-lined reactors and a Hastelloy C22 filter dryer, allowing the manufacture of batch sizes between 10 and 100 kilograms under cGMP conditions.